Related Experiment Video
Updated: Aug 5, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
Chronic morphine reduces pain-related disability in a rodent model of chronic, inflammatory pain
M D Lindner1, M A Plone, J M Francis
1CytoTherapeutics Incorporated, Lincoln, Rhode Island, USA. mlindner@neurocrine.com
Abstract:
Chronic pain is disabling, and the adverse effects of morphine are also disabling. The best way to assess the beneficial effects relative to the potential adverse effects of chronic morphine may be through the use of quantitative measures of functional disability in people and animals experiencing pain. If chronic morphine alleviates chronic pain and its beneficial analgesic effects outweigh whatever adverse effects it may produce, then it should reduce pain-related disability. Rats with adjuvant-induced arthritis were implanted with subcutaneous morphine pellets. Continuous morphine reduced pain-related disability in tasks motivated by food reward or shock avoidance throughout the 35 days of continuous administration--first, in tests that primarily assessed the function of the less severely affected forelimbs, and later, as the inflammation subsided, in tests more dependent on the function of the more severely affected hind limbs.
Insights
Chronic morphine effectively reduced pain-related disability in rats with arthritis over 35 days. This indicates morphine
Area of Science:
- Pharmacology
- Pain Management
- Animal Models
Background:
- Chronic pain and morphine's adverse effects cause significant disability.
- Quantitative measures of functional disability are crucial for assessing treatment efficacy.
- Morphine's net benefit depends on balancing pain relief against side effects.
Purpose of the Study:
- To evaluate the efficacy of continuous morphine administration in reducing pain-related functional disability in a rat arthritis model.
- To assess the relationship between morphine's analgesic effects and its impact on disability.
Main Methods:
- Adjuvant-induced arthritis was established in rats.
- Rats received continuous subcutaneous morphine via implanted pellets for 35 days.
- Pain-related functional disability was measured using tasks motivated by food reward or shock avoidance.
Main Results:
- Continuous morphine administration significantly reduced pain-related functional disability throughout the 35-day treatment period.
- Efficacy was observed in both forelimb and hindlimb function tests, reflecting the progression and subsidence of inflammation.
- Morphine demonstrated a net beneficial effect by alleviating disability despite potential adverse effects.
Conclusions:
- Continuous morphine is effective in reducing pain-related functional disability in a preclinical model of chronic pain.
- Quantitative functional measures provide a valuable assessment of chronic pain treatments.
- Morphine can offer significant functional benefits when its analgesic effects outweigh its adverse effects.
Related Concept Videos
Nociception
Analgesia and Pain Management

